C Weijer

How to design efficient cluster randomised trials

K Hemming, S Eldridge, G Forbes, 2017, British Medical Journal.

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework

C Weijer, M Taljaard, B Shea, 2017, BMJ Open.

A comparison of journal instructions regarding institutional review board approval and conflict-of-interest disclosure between 1995 and 2005

C Weijer, C. Weijer, C. Fernandez, 2008, Journal of Medical Ethics.

Protecting communities in pharmacogenetic and pharmacogenomic research

C Weijer, C. Weijer, P B Miller, 2004, The Pharmacogenomics Journal.

A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group.

C Weijer, B Freedman, C. Weijer, 1998, Journal of clinical epidemiology.